China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022

ReportsWorldwide has announced the addition of a new report title China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022 to its growing collection of premium market research reports.

China In-Vitro Diagnostics (IVD) market is likely to more than triple by 2022 from its current level in 2016. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. With an aging population, a rapidly growing middle class and a government encouraging preventive care, China IVD market is slated to show substantial growth in the future. China’s quickly aging population means the country is experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. Further, the average Chinese consumer is now willing and able to pay more for healthcare than a decade years ago. Hence, China has the potential for more dramatic growth in the future.

China IVD Market Segment Wise Analysis:

Immunoassay is the leading segment in China IVD market. Immunoassay is likely to maintain its dominant position in the forecasting period as well. Clinical Chemistry holds the 2nd position in China IVD market being followed by Molecular Testing. Microbiology and Hematology segments are competing closely with each other to grab maximum share of the pie.

China IVD Market Company Analysis:

In China IVD market, Roche Diagnostics is the leader in percent market share in 2016. Sysmex Corporation and Mindary Medical are other top two players in the China IVD market. At present, many local players are present in China IVD.

For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/china-in-vitro-diagnostics-ivd-market-company-analysis-forecast-to-2022

This is the 2nd edition report on China IVD Market. The report titled “China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022” studies in detail the China IVD Market - Application Segment Wise, Company Sales, Registration & Regulatory Status in China IVD & Driving Factors and Challenges for China IVD Market.

This 100 Page report with 34 Figures and 3 Tables has been analyzed from 8 View Points:

1) China IVD Market and Forecast (2007 - 2022)
2) China IVD Segment Wise Market & Forecast (2007 - 2022)
3) Development Environment and Regulatory Status in China IVD market 
4) Company Wise IVD Sales & Forecast (2010 - 2022)
5) Registration for In Vitro Diagnostic Reagents in China
6) Regulatory History/Status/Trends in China IVD Market
7) Profiles of Select Private Clinical Labs and Diagnostic Services Companies
8) China IVD Industry Drivers & Challenges

China IVD Market - 8 Application Segments Covered

1. Clinical Chemistry Market 
2. Immunoassay Market 
3. Hematology Market 
4. Coagulation Market 
5. Microbiology Market 
6. Molecular Testing Market
7. Self Monitoring of Blood Glucose (SMBG) Market 
8. Point of Care Testing (POCT) Market

Company Wise IVD Sales & Forecast

1. Roche Diagnostic
2. Abbott Laboratories
3. Sysmex Corporation
4. Mindray Medical International Limited
5. Shanghai Kehua Bio-Engineering Co. Ltd.
6. Others

Profiles of Private Clinical Labs and Diagnostic Services Companies in China

• Zhejiang Di’an Diagnostics Technology Co., Ltd
• ADICON Clinical Laboratories
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global (Privately held)
• BGI-Shenzhen (Privately held)
• OriGene Technologies (Privately held)

To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=40108

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
abigail@reportsworldwide.com

This release was published on openPR.